Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 507 is a human protein encoded by the ZNF507 gene, classified within the C2H2-type zinc finger protein family[1][2][4][7]. It functions primarily as a transcription factor, enabling DNA and metal ion binding, and is predicted to be involved in the positive regulation of transcription by RNA polymerase II[1][6]. ZNF507 shows specificity for binding to certain young subfamilies of LINE-1 (L1) retrotransposon sequences, possibly targeting them for transcriptional regulation during development[2]. Evidence suggests it physically interacts with the chromatin-modifying enzyme PRMT5, potentially recruiting it to LINE-1 elements and influencing local chromatin states and gene expression[2]. ZNF507 is mainly localized in the cell nucleus and implicated as a risk locus in some neurodevelopmental disorders; mutations are associated with Seckel syndrome 6[1][2]. While zinc finger proteins as a class are being explored for their roles in cancer, genomic stability, and DNA repair, ZNF507 itself has not yet been directly established as a therapeutic target or related to any approved drugs[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 507 (ZNF507).